{"transactions":[{"id":1089177,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-10T20:37:37.000Z","date":"2025-07-08","kind":"other","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Disposition of options pursuant to Merger Agreement."},{"field":"shares","element":"transactionShares","label":"F6","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":2.01,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001062993-25-012723","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1512119/000106299325012723/form4.xml","form_type":"4"}},{"id":1089176,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-10T20:37:37.000Z","date":"2025-07-08","kind":"other","planned":false,"acquired":false,"shares":56322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Disposition of options pursuant to Merger Agreement."},{"field":"shares","element":"transactionShares","label":"F6","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":5.7,"expiration_date":"2033-06-01","underlying":"Common Stock","underlying_shares":56322},"source":{"system":"sec-edgar","filing":"0001062993-25-012723","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1512119/000106299325012723/form4.xml","form_type":"4"}},{"id":1089175,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-10T20:37:37.000Z","date":"2025-07-08","kind":"other","planned":false,"acquired":false,"shares":30549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Disposition of options pursuant to Merger Agreement."},{"field":"shares","element":"transactionShares","label":"F6","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":11.24,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":30549},"source":{"system":"sec-edgar","filing":"0001062993-25-012723","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1512119/000106299325012723/form4.xml","form_type":"4"}},{"id":1089174,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-10T20:37:37.000Z","date":"2025-07-08","kind":"other","planned":false,"acquired":false,"shares":16860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Disposition of options pursuant to Merger Agreement."},{"field":"shares","element":"transactionShares","label":"F6","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":21.95,"expiration_date":"2031-05-21","underlying":"Common Stock","underlying_shares":16860},"source":{"system":"sec-edgar","filing":"0001062993-25-012723","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1512119/000106299325012723/form4.xml","form_type":"4"}},{"id":1089173,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-10T20:37:37.000Z","date":"2025-07-08","kind":"other","planned":false,"acquired":false,"shares":15937535,"ownership":{"direct":false,"nature":"See footnote 4"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition of shares pursuant to that certain Amended and Restated Agreement and Plan of Merger dated as of April 28, 2025, as amended (the \"Merger Agreement\"), by and among Quanterix Corporation, a Delaware corporation (\"Quanterix\"), Wellfleet Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Quanterix (\"Merger Sub\"), and Issuer. On July 8, 2025 (the \"Closing Date\"), Merger Sub merged with and into Issuer (the \"Merger\"), with Issuer surviving the Merger as a wholly owned subsidiary of Quanterix."},{"field":"shares","element":"transactionShares","label":"F2","text":"In connection with the terms of the Merger Agreement, each share of common stock of Issuer outstanding on the Closing Date was converted into the right to receive (a) 0.1461 of a share of common stock of Quanterix (the \"Per Share Stock Consideration\") and (b) $0.38 in cash, without interest (the \"Per Share Cash Consideration\" and together with the Per Share Stock Consideration, the \"Per Share Merger Consideration\"). Each of the Per Share Stock Consideration and the Per Share Cash Consideration may be adjusted pursuant to the terms of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the terms of the Merger Agreement, each share of common stock of Issuer outstanding on the Closing Date was converted into the right to receive (a) 0.1461 of a share of common stock of Quanterix (the \"Per Share Stock Consideration\") and (b) $0.38 in cash, without interest (the \"Per Share Cash Consideration\" and together with the Per Share Stock Consideration, the \"Per Share Merger Consideration\"). Each of the Per Share Stock Consideration and the Per Share Cash Consideration may be adjusted pursuant to the terms of the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held directly by Telegraph Hill Partners III, L.P. (\"THP III\"). THP IM is the general partner of THP III. THPMC is the manager of THP IM. J. Matthew Mackowski, Dr. Thomas A. Raffin and Deval Lashkari are each managers of THPMC and may be deemed to share voting and dispositive power over the securities held by THP III. Each of these individuals disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001062993-25-012723","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512119/000106299325012723/form4.xml","form_type":"4"}},{"id":1089172,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-10T20:37:37.000Z","date":"2025-07-08","kind":"other","planned":false,"acquired":false,"shares":1737712,"ownership":{"direct":false,"nature":"See footnote 3"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition of shares pursuant to that certain Amended and Restated Agreement and Plan of Merger dated as of April 28, 2025, as amended (the \"Merger Agreement\"), by and among Quanterix Corporation, a Delaware corporation (\"Quanterix\"), Wellfleet Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Quanterix (\"Merger Sub\"), and Issuer. On July 8, 2025 (the \"Closing Date\"), Merger Sub merged with and into Issuer (the \"Merger\"), with Issuer surviving the Merger as a wholly owned subsidiary of Quanterix."},{"field":"shares","element":"transactionShares","label":"F2","text":"In connection with the terms of the Merger Agreement, each share of common stock of Issuer outstanding on the Closing Date was converted into the right to receive (a) 0.1461 of a share of common stock of Quanterix (the \"Per Share Stock Consideration\") and (b) $0.38 in cash, without interest (the \"Per Share Cash Consideration\" and together with the Per Share Stock Consideration, the \"Per Share Merger Consideration\"). Each of the Per Share Stock Consideration and the Per Share Cash Consideration may be adjusted pursuant to the terms of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the terms of the Merger Agreement, each share of common stock of Issuer outstanding on the Closing Date was converted into the right to receive (a) 0.1461 of a share of common stock of Quanterix (the \"Per Share Stock Consideration\") and (b) $0.38 in cash, without interest (the \"Per Share Cash Consideration\" and together with the Per Share Stock Consideration, the \"Per Share Merger Consideration\"). Each of the Per Share Stock Consideration and the Per Share Cash Consideration may be adjusted pursuant to the terms of the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held directly by THP III Affiliates Fund, LLC (\"THP III AFF\"). Telegraph Hill Partners III Investment Management, LLC (\"THP IM\") is the manager of THP III AFF. Telegraph Hill Partners Management Company, LLC (\"THPMC\") is the manager of THP IM. J. Matthew Mackowski, Dr. Thomas A. Raffin and Deval Lashkari are each managers of THPMC and may be deemed to share voting and dispositive power over the securities held by THP III AFF. Each of these individuals disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001062993-25-012723","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512119/000106299325012723/form4.xml","form_type":"4"}},{"id":1089171,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-10T20:37:37.000Z","date":"2025-07-08","kind":"other","planned":false,"acquired":false,"shares":234592,"ownership":{"direct":false,"nature":"Thomas A. Raffin Living Trust dated March 29, 2017"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition of shares pursuant to that certain Amended and Restated Agreement and Plan of Merger dated as of April 28, 2025, as amended (the \"Merger Agreement\"), by and among Quanterix Corporation, a Delaware corporation (\"Quanterix\"), Wellfleet Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Quanterix (\"Merger Sub\"), and Issuer. On July 8, 2025 (the \"Closing Date\"), Merger Sub merged with and into Issuer (the \"Merger\"), with Issuer surviving the Merger as a wholly owned subsidiary of Quanterix."},{"field":"shares","element":"transactionShares","label":"F2","text":"In connection with the terms of the Merger Agreement, each share of common stock of Issuer outstanding on the Closing Date was converted into the right to receive (a) 0.1461 of a share of common stock of Quanterix (the \"Per Share Stock Consideration\") and (b) $0.38 in cash, without interest (the \"Per Share Cash Consideration\" and together with the Per Share Stock Consideration, the \"Per Share Merger Consideration\"). Each of the Per Share Stock Consideration and the Per Share Cash Consideration may be adjusted pursuant to the terms of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the terms of the Merger Agreement, each share of common stock of Issuer outstanding on the Closing Date was converted into the right to receive (a) 0.1461 of a share of common stock of Quanterix (the \"Per Share Stock Consideration\") and (b) $0.38 in cash, without interest (the \"Per Share Cash Consideration\" and together with the Per Share Stock Consideration, the \"Per Share Merger Consideration\"). Each of the Per Share Stock Consideration and the Per Share Cash Consideration may be adjusted pursuant to the terms of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001062993-25-012723","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512119/000106299325012723/form4.xml","form_type":"4"}},{"id":1332862,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:31:43.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10439,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":15.93,"expiration_date":"2026-07-31","underlying":"Common Stock","underlying_shares":10439},"source":{"system":"sec-edgar","filing":"0001126234-24-000117","document":"wk-form4_1734143494.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000117/wk-form4_1734143494.xml","form_type":"4"}},{"id":1332861,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:31:43.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2777,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":15.21,"expiration_date":"2029-05-09","underlying":"Common Stock","underlying_shares":2777},"source":{"system":"sec-edgar","filing":"0001126234-24-000117","document":"wk-form4_1734143494.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000117/wk-form4_1734143494.xml","form_type":"4"}},{"id":1332860,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:31:43.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2910,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":10.36,"expiration_date":"2031-05-19","underlying":"Common Stock","underlying_shares":2910},"source":{"system":"sec-edgar","filing":"0001126234-24-000117","document":"wk-form4_1734143494.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000117/wk-form4_1734143494.xml","form_type":"4"}},{"id":1332859,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:31:43.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3431,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":8.18,"expiration_date":"2032-05-04","underlying":"Common Stock","underlying_shares":3431},"source":{"system":"sec-edgar","filing":"0001126234-24-000117","document":"wk-form4_1734143494.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000117/wk-form4_1734143494.xml","form_type":"4"}},{"id":1332858,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:31:43.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5684,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":7.78,"expiration_date":"2030-04-02","underlying":"Common Stock","underlying_shares":5684},"source":{"system":"sec-edgar","filing":"0001126234-24-000117","document":"wk-form4_1734143494.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000117/wk-form4_1734143494.xml","form_type":"4"}},{"id":1332857,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:31:43.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3328,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option."}],"balance_after":0,"derivative":{"exercise_price":2.35,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":3328},"source":{"system":"sec-edgar","filing":"0001126234-24-000117","document":"wk-form4_1734143494.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000117/wk-form4_1734143494.xml","form_type":"4"}},{"id":1332856,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:31:43.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3345,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option."}],"balance_after":0,"derivative":{"exercise_price":3.42,"expiration_date":"2033-05-09","underlying":"Common Stock","underlying_shares":3345},"source":{"system":"sec-edgar","filing":"0001126234-24-000117","document":"wk-form4_1734143494.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000117/wk-form4_1734143494.xml","form_type":"4"}},{"id":1332855,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-13T21:31:43.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9406,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to that certain Agreement and Plan of Merger, dated October 22, 2024, by and between the Issuer, DPV Parent, Inc., DPV MergerSub, Inc. and Double Point Ventures LLC (\"DPV\") (the \"Merger Agreement\") in exchange for (i) $4.25 in cash per share (the \"Cash Amount\"), plus (ii) one non-transferable contingent value right (\"CVR\") per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001126234-24-000117","document":"wk-form4_1734143494.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000117/wk-form4_1734143494.xml","form_type":"4"}},{"id":1487321,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T16:07:11.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":3328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2009 Equity Incentive Plan (the \"Plan\"). One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant."}],"balance_after":3328,"derivative":{"exercise_price":2.35,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":3328},"source":{"system":"sec-edgar","filing":"0001126234-24-000074","document":"wk-form4_1717790822.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000074/wk-form4_1717790822.xml","form_type":"4"}},{"id":1489604,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T17:58:11.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuous service through the vesting date, the options shall vest in full on the earlier of (a) June 4, 2025, or (b) the date of the next annual meeting of Akoya Biosciences, Inc. occurring after the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":2.01,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-24-068750","document":"tm2416554-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512119/000110465924068750/tm2416554-6_4seq1.xml","form_type":"4"}},{"id":1858427,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-12T18:15:15.000Z","date":"2023-06-12","kind":"purchase","planned":false,"acquired":true,"shares":1803373,"price":5,"value":9016865.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held directly by Telegraph Hill Partners III, L.P. (\"THP III\"). THP IM is the general partner of THP III. THPMC is the manager of THP IM. J. Matthew Mackowski, Dr. Thomas A. Raffin and Deval Lashkari are each managers of THPMC and may be deemed to share voting and dispositive power over the securities held by THP III. Each of these individuals disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes."}],"balance_after":15937535,"source":{"system":"sec-edgar","filing":"0001104659-23-070479","document":"tm2318472-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512119/000110465923070479/tm2318472-1_4seq1.xml","form_type":"4"}},{"id":1858426,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-12T18:15:15.000Z","date":"2023-06-12","kind":"purchase","planned":false,"acquired":true,"shares":196627,"price":5,"value":983135.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held directly by THP III Affiliates Fund, LLC (\"THP III AFF\"). Telegraph Hill Partners III Investment Management, LLC (\"THP IM\") is the manager of THP III AFF. Telegraph Hill Partners Management Company, LLC (\"THPMC\") is the manager of THP IM. J. Matthew Mackowski, Dr. Thomas A. Raffin and Deval Lashkari are each managers of THPMC and may be deemed to share voting and dispositive power over the securities held by THP III AFF. Each of these individuals disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes."}],"balance_after":1737712,"source":{"system":"sec-edgar","filing":"0001104659-23-070479","document":"tm2318472-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512119/000110465923070479/tm2318472-1_4seq1.xml","form_type":"4"}},{"id":1858425,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-12T18:15:15.000Z","date":"2023-06-12","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":5,"value":100000.0,"ownership":{"direct":false,"nature":"Thomas A. Raffin Living Trust dated March 29, 2017"},"balance_after":234592,"source":{"system":"sec-edgar","filing":"0001104659-23-070479","document":"tm2318472-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512119/000110465923070479/tm2318472-1_4seq1.xml","form_type":"4"}},{"id":1866353,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-05T17:38:54.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":56322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuous service through the vesting date, the options shall vest in full on the earlier of (a) June 1, 2024, or (b) the date of the next annual meeting of Akoya Biosciences, Inc. occurring after the date of grant."}],"balance_after":56322,"derivative":{"exercise_price":5.7,"expiration_date":"2033-06-01","underlying":"Common Stock","underlying_shares":56322},"source":{"system":"sec-edgar","filing":"0001104659-23-068154","document":"tm2317841-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512119/000110465923068154/tm2317841-6_4seq1.xml","form_type":"4"}},{"id":1895390,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-12T17:44:52.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":3345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2009 Equity Incentive Plan (the \"Plan\"). One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant."}],"balance_after":3345,"derivative":{"exercise_price":3.42,"expiration_date":"2033-05-09","underlying":"Common Stock","underlying_shares":3345},"source":{"system":"sec-edgar","filing":"0001126234-23-000072","document":"wf-form4_168392787873750.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623423000072/wf-form4_168392787873750.xml","form_type":"4"}},{"id":2173127,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T17:00:21.000Z","date":"2022-08-25","kind":"purchase","acquired":true,"shares":1150,"price":8.46,"value":9729.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 237 restricted stock units (\"RSUs\") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the \"Plan\").  The RSUs will vest, and shares will be delivered to the Reporting Person in a single installment on April 3, 2023, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":9406,"source":{"system":"sec-edgar","filing":"0001126234-22-000093","document":"wf-form4_166154758329850.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623422000093/wf-form4_166154758329850.xml","form_type":"4"}},{"id":2243881,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy","published_at":"2022-06-03T16:04:21.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":30549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the reporting person's continuous service through the vesting date, the options shall vest in full on the earlier of (a) June 1, 2023, or (b) the date of the next annual meeting of Akoya Biosciences, Inc. occurring after the date of grant."}],"balance_after":30549,"derivative":{"exercise_price":11.24,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":30549},"source":{"system":"sec-edgar","filing":"0001104659-22-068068","document":"tm2217652-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1512119/000110465922068068/tm2217652-3_4seq1.xml","form_type":"4"}},{"id":2278092,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-09T17:10:34.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":3431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2009 Equity Incentive Plan (the \"Plan\"). One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant."}],"balance_after":3431,"derivative":{"exercise_price":8.18,"expiration_date":"2032-05-04","underlying":"Common Stock","underlying_shares":3431},"source":{"system":"sec-edgar","filing":"0001126234-22-000056","document":"wf-form4_165213059925731.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623422000056/wf-form4_165213059925731.xml","form_type":"4"}},{"id":2696613,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy","published_at":"2021-05-25T21:54:45.000Z","date":"2021-05-21","kind":"grant","acquired":true,"shares":16860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continuous service through the vesting date, the options shall vest in full on the earlier of (a) May 21, 2022, or (b) the date of the next annual meeting of Akoya Biosciences, Inc. occurring after the date of grant."}],"balance_after":16860,"derivative":{"exercise_price":21.95,"expiration_date":"2031-05-21","underlying":"Common Stock","underlying_shares":16860},"source":{"system":"sec-edgar","filing":"0001104659-21-072007","document":"tm2117585-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1512119/000110465921072007/tm2117585-3_4seq1.xml","form_type":"4"}},{"id":2699379,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-24T18:36:55.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":2910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the Reporting Person of a nonstatutory stock option under the Plan. One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant."}],"balance_after":2910,"derivative":{"exercise_price":10.36,"expiration_date":"2031-05-19","underlying":"Common Stock","underlying_shares":2910},"source":{"system":"sec-edgar","filing":"0001126234-21-000082","document":"wf-form4_162189580043228.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623421000082/wf-form4_162189580043228.xml","form_type":"4"}},{"id":2699378,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-24T18:36:55.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued as restricted stock units (\"RSUs\") under the Issuer's 2010 Non-Employee Director Stock Award Plan (the \"Plan\") that were received as an award, for no consideration.  The RSUs vest in a single installment on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 473 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on April 3, 2022, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":8256,"source":{"system":"sec-edgar","filing":"0001126234-21-000082","document":"wf-form4_162189580043228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623421000082/wf-form4_162189580043228.xml","form_type":"4"}},{"id":3180853,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-07T17:58:42.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":5684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant to the Reporting Person of a nonstatutory stock option under the Plan.  One-third of the shares vest on the one-year anniversary of the grant date and the remaining two-thirds of the shares vest in a series of 24 successive equal monthly installments thereafter, subject to the Reporting Persons's continuous service as of such dates.  The option expires ten years after the date of grant, unless it expires sooner pursuant to the terms of the Plan."}],"balance_after":5684,"derivative":{"exercise_price":7.78,"expiration_date":"2030-04-02","underlying":"Common Stock","underlying_shares":5684},"source":{"system":"sec-edgar","filing":"0001126234-20-000063","document":"wf-form4_158629670517355.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623420000063/wf-form4_158629670517355.xml","form_type":"4"}},{"id":3180852,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-07T17:58:42.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued as restricted stock units (\"RSUs\") under the Issuer's 2010 Non-Employee Director Stock Award Plan (the \"Plan\") that were received as an award, for no consideration.  The RSUs vest in a series of three successive annual installments beginning on April 3, 2021, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":7889,"source":{"system":"sec-edgar","filing":"0001126234-20-000063","document":"wf-form4_158629670517355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623420000063/wf-form4_158629670517355.xml","form_type":"4"}},{"id":3449462,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":13889,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every two cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 50% on the first anniversary of grant date and the remaining 50% on the second anniversary of grant date."}],"balance_after":13889,"derivative":{"exercise_price":1.77,"expiration_date":"2026-07-31","underlying":"Common Stock","underlying_shares":13889},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449461,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"disposition_to_issuer","acquired":false,"shares":27777,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every two cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option provided that one hundred percent (100%) of the shares would vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date."}],"balance_after":0,"derivative":{"exercise_price":5.33,"expiration_date":"2028-05-22","underlying":"Common Stock","underlying_shares":27777},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449460,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":4437,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every three cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 50% on the first anniversary of grant date and the remaining 50% on the second anniversary of grant date."}],"balance_after":4437,"derivative":{"exercise_price":1.77,"expiration_date":"2026-07-31","underlying":"Common Stock","underlying_shares":4437},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449459,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"disposition_to_issuer","acquired":false,"shares":13309,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every three cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option provided that one hundred percent (100%) of the shares would vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date."}],"balance_after":0,"derivative":{"exercise_price":17.42,"expiration_date":"2027-05-11","underlying":"Common Stock","underlying_shares":13309},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449458,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":2391,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every two cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 50% on the first anniversary of grant date and the remaining 50% on the second anniversary of grant date."}],"balance_after":2391,"derivative":{"exercise_price":1.77,"expiration_date":"2026-07-31","underlying":"Common Stock","underlying_shares":2391},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449457,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"disposition_to_issuer","acquired":false,"shares":4782,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every two cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option provided that one hundred percent (100%) of the shares would vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date."}],"balance_after":0,"derivative":{"exercise_price":10.78,"expiration_date":"2026-08-08","underlying":"Common Stock","underlying_shares":4782},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449456,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":8887,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every two cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 50% on the first anniversary of grant date and the remaining 50% on the second anniversary of grant date."}],"balance_after":8887,"derivative":{"exercise_price":1.77,"expiration_date":"2026-07-31","underlying":"Common Stock","underlying_shares":8887},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449455,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"disposition_to_issuer","acquired":false,"shares":17774,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every two cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option provided that one hundred percent (100%) of the shares would vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date."}],"balance_after":0,"derivative":{"exercise_price":10.78,"expiration_date":"2026-08-08","underlying":"Common Stock","underlying_shares":17774},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449454,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":1588,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every four cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 50% on the first anniversary of grant date and the remaining 50% on the second anniversary of grant date."}],"balance_after":1588,"derivative":{"exercise_price":1.77,"expiration_date":"2026-07-31","underlying":"Common Stock","underlying_shares":1588},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449453,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"disposition_to_issuer","acquired":false,"shares":6349,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every four cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option provided that one hundred percent (100%) of the shares would vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date."}],"balance_after":0,"derivative":{"exercise_price":44.6,"expiration_date":"2025-04-29","underlying":"Common Stock","underlying_shares":6349},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449452,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":5220,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every three cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 50% on the first anniversary of grant date and the remaining 50% on the second anniversary of grant date."}],"balance_after":5220,"derivative":{"exercise_price":1.77,"expiration_date":"2026-07-31","underlying":"Common Stock","underlying_shares":5220},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449451,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"disposition_to_issuer","acquired":false,"shares":15659,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every three cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option provided that one hundred percent (100%) of the shares would vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date."}],"balance_after":0,"derivative":{"exercise_price":21.23,"expiration_date":"2024-04-30","underlying":"Common Stock","underlying_shares":15659},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449450,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every three cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 50% on the first anniversary of grant date and the remaining 50% on the second anniversary of grant date."}],"balance_after":4000,"derivative":{"exercise_price":1.77,"expiration_date":"2026-07-31","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449449,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"disposition_to_issuer","acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every three cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option provided that one hundred percent (100%) of the shares would vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date."}],"balance_after":0,"derivative":{"exercise_price":14.71,"expiration_date":"2023-05-08","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449448,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":5952,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every three cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 50% on the first anniversary of grant date and the remaining 50% on the second anniversary of grant date."}],"balance_after":5952,"derivative":{"exercise_price":1.77,"expiration_date":"2026-07-31","underlying":"Common Stock","underlying_shares":5952},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449447,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"disposition_to_issuer","acquired":false,"shares":17855,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every three cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option provided that 50% of the option vested on November 2, 2013 and the remaining 50% of such option vested in equal monthly installments over the next 12 months, provided (i) that the option shall vest in full on the date of the Annual Meeting held two years after the date of grant and (ii) that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":0,"derivative":{"exercise_price":13.3,"expiration_date":"2022-11-01","underlying":"Common Stock","underlying_shares":17855},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449446,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":23810,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every two cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 50% on the first anniversary of grant date and the remaining 50% on the second anniversary of grant date."}],"balance_after":23810,"derivative":{"exercise_price":1.77,"expiration_date":"2026-07-31","underlying":"Common Stock","underlying_shares":23810},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449445,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"disposition_to_issuer","acquired":false,"shares":47619,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every two cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."}],"balance_after":0,"derivative":{"exercise_price":7,"exercise_date":"2011-11-10","expiration_date":"2021-11-09","underlying":"Common Stock","underlying_shares":47619},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449444,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":1786,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every two cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 50% on the first anniversary of grant date and the remaining 50% on the second anniversary of grant date."}],"balance_after":1786,"derivative":{"exercise_price":1.77,"expiration_date":"2026-07-31","underlying":"Common Stock","underlying_shares":1786},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449443,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"disposition_to_issuer","acquired":false,"shares":3571,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every two cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."}],"balance_after":0,"derivative":{"exercise_price":7,"exercise_date":"2011-12-09","expiration_date":"2021-11-09","underlying":"Common Stock","underlying_shares":3571},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449442,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":8929,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every two cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 50% on the first anniversary of grant date and the remaining 50% on the second anniversary of grant date."}],"balance_after":8929,"derivative":{"exercise_price":1.77,"expiration_date":"2026-07-31","underlying":"Common Stock","underlying_shares":8929},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449441,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"disposition_to_issuer","acquired":false,"shares":17857,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every two cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."}],"balance_after":0,"derivative":{"exercise_price":10.02,"exercise_date":"2012-01-01","expiration_date":"2020-12-08","underlying":"Common Stock","underlying_shares":17857},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449440,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":13095,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every two cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 50% on the first anniversary of grant date and the remaining 50% on the second anniversary of grant date."}],"balance_after":13095,"derivative":{"exercise_price":1.77,"expiration_date":"2026-07-31","underlying":"Common Stock","underlying_shares":13095},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3449439,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T18:37:30.000Z","date":"2019-07-31","kind":"disposition_to_issuer","acquired":false,"shares":26190,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program.  In exchange, for every two cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share."}],"balance_after":0,"derivative":{"exercise_price":3.07,"exercise_date":"2011-03-03","expiration_date":"2020-03-02","underlying":"Common Stock","underlying_shares":26190},"source":{"system":"sec-edgar","filing":"0001126234-19-000099","document":"wf-form4_156478543324927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000099/wf-form4_156478543324927.xml","form_type":"4"}},{"id":3527921,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-14T17:32:51.000Z","date":"2019-05-10","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Automatic grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2009 Equity Incentive Plan, as amended (the \"Plan\").  One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date.  The option expires ten years after the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":1.69,"expiration_date":"2029-05-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001126234-19-000057","document":"wf-form4_155786955720528.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623419000057/wf-form4_155786955720528.xml","form_type":"4"}},{"id":3917314,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-25T18:01:15.000Z","date":"2018-05-23","kind":"grant","acquired":true,"shares":27777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Automatic grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2009 Equity Incentive Plan (the \"Plan\").  One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date.  The option expires ten years after the date of grant."}],"balance_after":27777,"derivative":{"exercise_price":5.33,"expiration_date":"2028-05-22","underlying":"Common Stock","underlying_shares":27777},"source":{"system":"sec-edgar","filing":"0001126234-18-000101","document":"wf-form4_152728565933634.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623418000101/wf-form4_152728565933634.xml","form_type":"4"}},{"id":4318646,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":77559,"kind":"person","name":"Raffin Thomas A.","position":1,"cik":"0001512119","reported_name":"Raffin Thomas A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-16T17:20:59.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":13309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Automatic grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2009 Equity Incentive Plan (the \"Plan\").  One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date.  The option expires ten years after the date of grant."}],"balance_after":13309,"derivative":{"exercise_price":17.42,"expiration_date":"2027-05-11","underlying":"Common Stock","underlying_shares":13309},"source":{"system":"sec-edgar","filing":"0001126234-17-000053","document":"wf-form4_149496964466627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623417000053/wf-form4_149496964466627.xml","form_type":"4"}}]}